[Federal Register Volume 85, Number 84 (Thursday, April 30, 2020)]
[Notices]
[Pages 23982-23983]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09244]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Integrating Biospecimen Science Approaches into Clinical 
Assay Development.
    Date: June 11, 2020.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, Medical Center 
Drive, Room 7W242, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Bethesda, MD 20892, 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-4: NCI Clinical and Translational R21 and Omnibus R03 
Review.

[[Page 23983]]

    Date: June 12, 2020.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W112, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jennifer C. Schiltz, Ph.D., Special Review 
Branch, Division of Extramural Activities, National Cancer 
Institute, 9609 Medical Center Drive, Room 7W112, Rockville, MD 
20850, 240-276-5864, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Small Cell Lung Cancer Consortium.
    Date: June 16, 2020.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove Medical Center 
Drive, Room 7W116, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Klaus B. Piontek, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, 9609 Medical Center Drive, Room 7W116, National Cancer 
Institute, Rockville, MD 20892-9750, 240-276-5413, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Utilizing the Prostate, Lung, Colorectal, and Ovarian Cancer 
(PLCO) Biospecimens Resources (U01).
    Date: June 23, 2020.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W122, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Anita T. Tandle, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W122, Bethesda, MD 20892, 240-276-5085, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Radiobiology of High Linear Energy Transfer Exposure in 
Cancer Treatment.
    Date: June 25, 2020.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Bethesda, MD 20892-8329, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-6: NCI Clinical and Translational R21 and Omnibus R03 
Review.
    Date: June 26, 2020.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert Stephen Coyne, Ph.D., Scientific Review 
Officer, National Cancer Institute, NIH Division of Extramural 
Activities, Special Review Branch, 9609 Medical Center Drive, Room 
7W236, Rockville, MD 20850, 240-276-5120, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Pathway to Independence Award for Outstanding Early Stage 
Postdoctoral Researchers.
    Date: July 1, 2020.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W238, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Rockville, MD 20850, 240-276-7755, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: April 27, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-09244 Filed 4-29-20; 8:45 am]
BILLING CODE 4140-01-P